HumanFirst (Pharmaceuticals and Biotechnology) Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 33

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $13.3M

HumanFirst (Pharmaceuticals and Biotechnology) General Information

Description

Developer of a SaaS-based, AI-powered insights and evidence platform designed to help biopharma companies accelerate patient-centered research and drive research and development efficiency. The company's platform & industry educational tools include evidence from validated digital health technologies, digital biomarkers, electronic clinical outcome assessment and research partners, enabling biopharma organizations to incorporate precision measures in their clinical research and bring better treatments to market, faster.

Contact Information

Formerly Known As
Elektra Labs
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 548 Market Street
  • Private Mail Box 82305
  • San Francisco, CA 94104-5401
  • United States
Primary Industry
Other Pharmaceuticals and Biotechnology
Parent Company
Vertical(s)
Corporate Office
  • 548 Market Street
  • Private Mail Box 82305
  • San Francisco, CA 94104-5401
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HumanFirst (Pharmaceuticals and Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 09-Jan-2024 $13.3M Completed Generating Revenue
5. Early Stage VC (Series A) 01-Jun-2021 Completed Generating Revenue
4. Early Stage VC (Series A) 12-Nov-2019 Completed Generating Revenue
3. Accelerator/Incubator 06-Sep-2019 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2018 Completed Startup
1. Accelerator/Incubator 01-Jan-2017 Completed Startup
To view HumanFirst (Pharmaceuticals and Biotechnology)’s complete valuation and funding history, request access »

HumanFirst (Pharmaceuticals and Biotechnology) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Series A-1
Series A-2 2,460,301 $0.000005 $1.19 $1.19 1x $1.19 17.99%
To view HumanFirst (Pharmaceuticals and Biotechnology)’s complete cap table history, request access »

HumanFirst (Pharmaceuticals and Biotechnology) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HumanFirst (Pharmaceuticals and Biotechnology) Former Investors (32)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel (individual) Minority
Angel (individual) Minority
Arkitekt Ventures Venture Capital Minority
Angel (individual) Minority
Boost VC Accelerator/Incubator Minority
You’re viewing 5 of 32 investors. Get the full list »

HumanFirst (Pharmaceuticals and Biotechnology) FAQs

  • When was HumanFirst (Pharmaceuticals and Biotechnology) founded?

    HumanFirst (Pharmaceuticals and Biotechnology) was founded in 2017.

  • Where is HumanFirst (Pharmaceuticals and Biotechnology) headquartered?

    HumanFirst (Pharmaceuticals and Biotechnology) is headquartered in San Francisco, CA.

  • What is the size of HumanFirst (Pharmaceuticals and Biotechnology)?

    HumanFirst (Pharmaceuticals and Biotechnology) has 33 total employees.

  • What industry is HumanFirst (Pharmaceuticals and Biotechnology) in?

    HumanFirst (Pharmaceuticals and Biotechnology)’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is HumanFirst (Pharmaceuticals and Biotechnology) a private or public company?

    HumanFirst (Pharmaceuticals and Biotechnology) is a Private company.

  • What is the current valuation of HumanFirst (Pharmaceuticals and Biotechnology)?

    The current valuation of HumanFirst (Pharmaceuticals and Biotechnology) is .

  • What is HumanFirst (Pharmaceuticals and Biotechnology)’s current revenue?

    The current revenue for HumanFirst (Pharmaceuticals and Biotechnology) is .

  • How much funding has HumanFirst (Pharmaceuticals and Biotechnology) raised over time?

    HumanFirst (Pharmaceuticals and Biotechnology) has raised $14.9M.

  • Who are HumanFirst (Pharmaceuticals and Biotechnology)’s investors?

    , , Arkitekt Ventures, , and Boost VC are 5 of 32 investors who have invested in HumanFirst (Pharmaceuticals and Biotechnology).

  • When was HumanFirst (Pharmaceuticals and Biotechnology) acquired?

    HumanFirst (Pharmaceuticals and Biotechnology) was acquired on 09-Jan-2024.

  • Who acquired HumanFirst (Pharmaceuticals and Biotechnology)?

    HumanFirst (Pharmaceuticals and Biotechnology) was acquired by Icon (Dublin).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process